nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Access to clinical trial data—Commentary
|
Devereaux, PJ |
|
2019 |
16 |
5 |
p. 552-554 |
artikel |
2 |
A novel, hybrid, single- and multi-site clinical trial design for CLN3 disease, an ultra-rare lysosomal storage disorder
|
Adams, Heather R |
|
2019 |
16 |
5 |
p. 555-560 |
artikel |
3 |
Creation of an institutional semi-independent data monitoring committee
|
Tannock, Lisa R |
|
2019 |
16 |
5 |
p. 523-530 |
artikel |
4 |
Design and analysis of a clinical trial using previous trials as historical control
|
Schoenfeld, David Alan |
|
2019 |
16 |
5 |
p. 531-538 |
artikel |
5 |
Detection of atypical data in multicenter clinical trials using unsupervised statistical monitoring
|
Trotta, Laura |
|
2019 |
16 |
5 |
p. 512-522 |
artikel |
6 |
Editorial
|
Begg, Colin B |
|
2019 |
16 |
5 |
p. 446 |
artikel |
7 |
Ethical complexities of responding to bystander risk in HIV prevention trials
|
Eyal, Nir |
|
2019 |
16 |
5 |
p. 458-460 |
artikel |
8 |
Facebook advertising for recruitment of midlife women with bothersome vaginal symptoms: A pilot study
|
Guthrie, Katherine A |
|
2019 |
16 |
5 |
p. 476-480 |
artikel |
9 |
Impact of retrospective data verification to prepare the ICON6 trial for use in a marketing authorization application
|
Embleton-Thirsk, Andrew |
|
2019 |
16 |
5 |
p. 502-511 |
artikel |
10 |
Objective monitoring of mosquito bednet usage and the ethical challenge of privacy revelations about study bystanders: Ethical analysis
|
Fairchild, Amy L |
|
2019 |
16 |
5 |
p. 469-472 |
artikel |
11 |
Objective monitoring of mosquito bednet usage and the ethical challenge of respecting study bystanders’ privacy
|
Krezanoski, Paul |
|
2019 |
16 |
5 |
p. 466-468 |
artikel |
12 |
Open science: The open clinical trials data journey
|
Rockhold, Frank |
|
2019 |
16 |
5 |
p. 539-546 |
artikel |
13 |
Organ donor intervention trials and risk to bystanders: An ethical analysis
|
Cohen, Ivan Glenn |
|
2019 |
16 |
5 |
p. 463-465 |
artikel |
14 |
Organ donor intervention trials and the ethical challenge of bystander organ recipients
|
Kimmelman, Jonathan |
|
2019 |
16 |
5 |
p. 461-462 |
artikel |
15 |
Recruitment and retention: A randomized controlled trial of video-enhanced versus standard consent processes within the E-OPTIMAL study
|
Brubaker, Linda |
|
2019 |
16 |
5 |
p. 481-489 |
artikel |
16 |
Regulating impact on bystanders in clinical trials: An unsettled frontier
|
Eyal, Nir |
|
2019 |
16 |
5 |
p. 450-454 |
artikel |
17 |
Research methodology and practical issues relating to the conduct of a medical device registry
|
Bisdas, Theodosios |
|
2019 |
16 |
5 |
p. 490-501 |
artikel |
18 |
Risk to bystanders in clinical trials: A symposium
|
Eyal, Nir |
|
2019 |
16 |
5 |
p. 447-449 |
artikel |
19 |
Sex partners as bystanders in HIV prevention trials: Two test cases for research ethics
|
Bärnighausen, Till |
|
2019 |
16 |
5 |
p. 455-457 |
artikel |
20 |
The ethical relevance of two types of adverse health effects on research bystanders as applied to HIV, mosquito bednet and organ transplant trials
|
Vong, Gerard |
|
2019 |
16 |
5 |
p. 473-475 |
artikel |
21 |
Transparency and objectivity in governance of clinical trials data sharing: Current practices and approaches
|
Shabani, Mahsa |
|
2019 |
16 |
5 |
p. 547-551 |
artikel |